Summary
The influence of cimetidine on its own pharmacokinetics after subchronic administration was assessed in 8 healthy volunteers, aged 26–29 years. On control Day 1, each subject received cimetidine 300 mg i.v., and serum and urine samples were obtained. Each subject was initiated on cimetidine 600 mg b.i.d. orally for 2 weeks. There were 3 further study days repeated after 1 and 2 weeks of cimetidine dosing and 1 week after stopping cimetidine. There was no significant difference in the mean total body clearance of cimetidine among the 4 study days. Mean elimination t1/2β and Vβ were similarly unchanged. However mean renal clearance (CLR) and fe were significantly increased following 2 weeks of drug dosing (CLR 5.41 ml·min−1 kg−1; fe 0.61) compared to control (CLR 4.00 ml·min−1·kg−1; fe 0.48). Although the non renal clearance was reduced from control values of 4.29 to 3.51 ml·min−1·kg−1 following 2 weeks of dosing the difference was not significant. Dosage adjustment of cimetidine appears unnecessary after short-term dosing in the presence of normal renal function.
References
Guay DRP, Matzke GR, Bockbrader HN et al. (1983) Comparison of bioavailability and pharmacokinetics of cimetidine in subjects with normal and impaired renal function. Clin Pharm 2: 157–162
Somogyi A, Rohner HG, Gugler R (1980) Pharmacokinetics and bioavailability of cimetidine in gastric and duodenal ulcer patients. Clin Pharmacokinet 5: 84–94
Larsson R, Erlanson P, Bodemar G et al. (1982) The pharmacokinetics of cimetidine and its sulphoxide metabolite in patients with normal and impaired renal function. Br J Clin Pharmacol 13: 163–170
Grahnen A, von Bahr C, Lindstrom B et al. (1979) Bioavailability and pharmacokinetics of cimetidine. Eur J Clin Pharmacol 16: 335–340
Burland WL, Duncan WAM, Hesselbo T et al. (1975) Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy mean. Br J Clin Pharmacol 2: 481–486
Schentag JJ, Cerra FB, Calleri GM et al. (1981) Age, disease and cimetidine disposition in healthy subjects and chronically ill patients. Clin Pharmacol Ther 29: 737–743
Taylor DC, Cresswell PR, Bartlett DC (1978) The metabolism and elimination of cimetidine, a histamine H2-receptor antagonist in the rat, dog and man. Drug Metab Dispos 6: 21–30
Sedman AJ (1984) Cimetidine-drug interactions. Am J Med 76: 109–114
Somogyi A, Gugler A (1982) Drug interactions with cimetidine. Clin Pharmacokinet 7: 23–41
Soldin SJ, Fingold DR, Fenje PC et al. (1979) High performance liquid chromatographic analysis of cimetidine in serum. Ther Drug Monitor 1: 371–379
Gibaldi M, Perrier D (1982) Pharmacokinetics. Marcel Dekker, New York
Lebert PA, Mahon WA, MacLeod SM et al. (1981) Ranitidine kinetics and dynamics. II. Intravenous dose studies and comparison with cimetidine. Clin Pharmacol Ther 30: 545–550
Bodemar G, Norlander B, Walan A (1981) Pharmacokinetics of cimetidine after single doses and during continuous treatment. Clin Pharmacokinet 6: 306–315
Mantyl R, Klinge E, Nykanen S et al. (1980) Pharmacokinetics of single and multiple oral doses of cimetidine in healthy nonfasting volunteers. Naunyn Schmiedebergs Arch Pharmacol 313 [Suppl]: R54
Bodemar G, Norlander B, Fransson L et al. (1979) The absorption of cimetidine before and during maintenance treatment with cimetidine and the influence of a meal on the absorption of cimetidine-studies in patients with peptic ulcer disease. Br J Clin Pharmacol 7: 23–31
Webster J, Barber HE, Hawksworth GM et al. (1981) Cimetidine — a clinical and pahrmacokinetic study. Br J Clin Pharmacol 11: 333–338
Mihaly GW, Jones DB, Anderson JA et al. (1984) Pharmacokinetic studies of cimetidine and ranitidine before and after treatment in peptic ulcer patients. Br J Clin Pharmacol 17: 109–111
Patwardhan RV, Johnson RF, Sinclair AP et al. (1981) Lack of tolerance and rapid recovery of cimetidine-inhibited chlordiazepoxide (Librium) elimination. Gastroenterol 81: 547–551
Vestal RE, Thummel KE, Musser B (1983) Cimetidine inhibits theophylline clearance in patients with chronic obstructive pulmonary disease — a study using stable isotope methodology during multiple oral dose administration. Br J Clin Pharmacol 15: 411–418
Speeg KV, Patwardhan RV, Avant GR et al. (1982) Inhibition of microsomal drug metabolism by histamine H2-receptor antagonists studied in vivo and in vitro in rodents. Gastroenterol 82: 89–96
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chin, T.W.F., Spino, M., MacLeod, S.M. et al. Pharmacokinetics of cimetidine after subchronic administration. Eur J Clin Pharmacol 30, 741–744 (1986). https://doi.org/10.1007/BF00608228
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00608228